UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 194

Sortiert nach

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review

Cancer treatment reviews, 2008-05, Vol.34 (3), p.193-205

2008

Volltextzugriff (PDF)

Primary and subsequent coronary risk appraisal: New results from the Framingham study

The American heart journal, 2000-02, Vol.139 (2), p.272-281

2000

Volltextzugriff (PDF)

A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients

BMC health services research, 2009-06, Vol.9 (1), p.111-111, Article 111

2009

Volltextzugriff (PDF)

Assessment of the Economic Burden of COPD in the U.S.: A Review and Synthesis of the Literature

Chronic obstructive pulmonary disease, 2006-01, Vol.3 (4), p.211-218

2006

Volltextzugriff (PDF)

Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain

Clinical therapeutics, 2010-09, Vol.32 (10), p.1768-1781

2010

Volltextzugriff (PDF)

Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis

Journal of rheumatology, 2003-04, Vol.30 (4), p.714

2003

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis

Clinical therapeutics, 2012-05, Vol.34 (5), p.1132-1144

2012

Volltextzugriff (PDF)

The economic burden of metastatic breast cancer: A systematic review of literature from developed countries

Cancer treatment reviews, 2011-10, Vol.37 (6), p.405-415

2011

Volltextzugriff (PDF)

Current challenges in health economic modeling of cancer therapies: a research inquiry

American health & drug benefits, 2014-05, Vol.7 (3), p.153-162

2014

Volltextzugriff (PDF)

Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey

The American journal of managed care, 2002-10, Vol.8 (15 Suppl), p.S383-S391

2002

Volltextzugriff (PDF)

Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain

Current medical research and opinion, 2009-07, Vol.25 (7), p.1763-1773

2009

Volltextzugriff (PDF)

Economic Burden of Follicular Non-Hodgkin’s Lymphoma

PharmacoEconomics, 2009-01, Vol.27 (8), p.657-679

2009

Volltextzugriff (PDF)

Excess Mortality, Length of Stay, and Costs Associated with Serious Hemorrhage among Trauma Patients : Findings from the National Trauma Data Bank

The American surgeon, 2007-12, Vol.73 (12), p.1269-1274

2007

Volltextzugriff (PDF)

Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden

ClinicoEconomics and outcomes research, 2016-01, Vol.8, p.657-666

2016

Volltextzugriff (PDF)

M1024 Does the Dosing Frequency of Proton Pump Inhibitors (PPIs) Affect Medication Adherence Among Patients Diagnosed with Gastroesophageal Reflux Disease (GERD)?

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-321-A-322

2008

Volltextzugriff (PDF)

Direct Costs of COPD in the U.S.: An Analysis of Medical Expenditure Panel Survey (MEPS) Data

Chronic obstructive pulmonary disease, 2005, Vol.2 (3), p.311-318

2005

Volltextzugriff (PDF)

Direct Medical Costs of Coronary Artery Disease in the United States

The American journal of cardiology, 1998-05, Vol.81 (9), p.1110-1115

1998

Volltextzugriff (PDF)

Cost-utility of somatropin (rDNA origin) in the treatment of growth hormone deficiency in children

Current medical research and opinion, 2006-02, Vol.22 (2), p.351-357

2006

Volltextzugriff (PDF)

Cost-effectiveness of statins

The American journal of cardiology, 1998-12, Vol.82 (11), p.1357-1363

1998

Volltextzugriff (PDF)

Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation

The American journal of managed care, 2002-01, Vol.8 (1 Suppl), p.S10-S16

2002

Volltextzugriff (PDF)

Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients

The American journal of managed care, 2002-01, Vol.8 (1 Suppl), p.S3-S9

2002

Volltextzugriff (PDF)

The economic burden of intracerebral hemorrhage: evidence from managed care

Managed care interface, 2006-06, Vol.19 (6), p.24

2006

Volltextzugriff (PDF)

Dalteparin vs. enoxaparin as prophylaxis for deep-vein thrombosis after total hip or knee arthroplasty: a retrospective analysis

American journal of physical medicine & rehabilitation, 2001-12, Vol.80 (12), p.889

2001

Volltextzugriff (PDF)

P-490: Projected risks and costs of cardiovascular disease due to increased systolic blood pressure associated with use of rofecoxib

American journal of hypertension, 2001-04, Vol.14 (S1), p.195A-195A

2001

Volltextzugriff (PDF)

Outcomes of dalteparin use following total knee arthroplasty: a retrospective analysis

Expert review of pharmacoeconomics & outcomes research, 2002-10, Vol.2 (5), p.427-434

2002

Volltextzugriff (PDF)

1 – 25 von 194

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(173)

Publikationsform

Sprache

Englisch
(191)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(110)
Humans
(79)
Male
(54)
Middle Aged
(37)
Aged
(36)
Biological And Medical Sciences
(34)
Female
(33)
Adult
(27)
Medical Sciences
(22)
Physical Sciences
(22)
Risk Factors
(15)
Oncology
(14)
Treatment Outcome
(14)
Fundamental And Applied Biological Sciences. Psychology
(13)
General & Internal Medicine
(13)
Medicine, General & Internal
(13)
Prostatic Neoplasms - Drug Therapy
(13)
Agriculture
(12)
Prostate Cancer
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review

Primary and subsequent coronary risk appraisal: New results from the Framingham study

A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients

Assessment of the Economic Burden of COPD in the U.S.: A Review and Synthesis of the Literature

Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain

Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis

Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis

The economic burden of metastatic breast cancer: A systematic review of literature from developed countries

Current challenges in health economic modeling of cancer therapies: a research inquiry

Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey

Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain

Economic Burden of Follicular Non-Hodgkin’s Lymphoma

Excess Mortality, Length of Stay, and Costs Associated with Serious Hemorrhage among Trauma Patients : Findings from the National Trauma Data Bank

Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden

M1024 Does the Dosing Frequency of Proton Pump Inhibitors (PPIs) Affect Medication Adherence Among Patients Diagnosed with Gastroesophageal Reflux Disease (GERD)?

Direct Costs of COPD in the U.S.: An Analysis of Medical Expenditure Panel Survey (MEPS) Data

Direct Medical Costs of Coronary Artery Disease in the United States

Cost-utility of somatropin (rDNA origin) in the treatment of growth hormone deficiency in children

Cost-effectiveness of statins

Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation

Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients

The economic burden of intracerebral hemorrhage: evidence from managed care

Dalteparin vs. enoxaparin as prophylaxis for deep-vein thrombosis after total hip or knee arthroplasty: a retrospective analysis

P-490: Projected risks and costs of cardiovascular disease due to increased systolic blood pressure associated with use of rofecoxib

Outcomes of dalteparin use following total knee arthroplasty: a retrospective analysis

Suchergebnisse filtern